121
Participants
Start Date
December 13, 2021
Primary Completion Date
March 30, 2023
Study Completion Date
March 30, 2023
NYX-783
NYX-783
Placebo
Placebo for 50 mg NYX-783
Aptinyx Clinical Site, New York
Aptinyx Clinical Site, Media
Aptinyx Clinical Site, Atlanta
Aptinyx Clinical Site, Jacksonville
Aptinyx Clinical Site, Orlando
Aptinyx Clinical Site, Hialeah
Aptinyx Clinical Site, Miami Lakes
Aptinyx Clinical Site, Hollywood
Aptinyx Clinical Site, Miami
Aptinyx Clinical Site, Miami
Aptinyx Clinical Site, Jupiter
Aptinyx Clinical Site, Okeechobee
Aptinyx Clinical Site, Tuscaloosa
Aptinyx Clinical Site, Memphis
Aptinyx Clinical Site, North Canton
Aptinyx Clinical Site, Cincinnati
Aptinyx Clinical Site, Dayton
Aptinyx Clinical Site, Kettering
Aptinyx Clinical Site, Bentonville
Aptinyx Clinical Site, Plano
Aptinyx Clinical Site, Fort Worth
Aptinyx Clinical Site, Houston
Aptinyx Clinical Site, Austin
Aptinyx Clinical Site, Denver
Aptinyx Clinical Site, Colorado Springs
Aptinyx Clinical Site, Phoenix
Aptinyx Clinical Site, Albuquerque
Aptinyx Clinical Site, Las Vegas
Aptinyx Clinical Site, Torrance
Aptinyx Clinical Site, Bellflower
Aptinyx Clinical Site, Glendale
Aptinyx Clinical Site, La Jolla
Aptinyx Clinical Site, Oceanside
Aptinyx Clinical Site, Riverside
Aptinyx Clinical Site, Temecula
Aptinyx Clinical Site, Santa Ana
Aptinyx Clinical Site, Boston
Lead Sponsor
Collaborators (1)
Worldwide Clinical Trials
OTHER
Aptinyx
INDUSTRY